Key points are not available for this paper at this time.
Increasing antibacterial resistance in Neisseria gonorrhoeae is threatening the success of routine treatment. This letter describes the clinical failure of ceftriaxone and azithromycin in a patient with gonorrhea.
Fifer et al. (Thu,) studied this question.